跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,125 条关于
“mesolimbic reward pathway”
全部
8,125
临床试验
2,648
药物
87
机构
49
资讯
5,341
去年
FDA Fast-Tracks Novel Drug PP-01 for Cannabis Withdrawal Syndrome Treatment
3个月前
Arizona Treatment Center Pioneers GLP-1 Peptide Use in Addiction Recovery
11个月前
PleoPharma Raises $36M Series B to Advance First-in-Class Cannabis Withdrawal Treatment to Phase 3
3个月前
PleoPharma Doses First Patient in Pivotal Phase 3 Trial of PP-01 for Cannabis Withdrawal, Presents Phase 2 Data Showing 43% Reduction in Irritability
去年
Eli Lilly to Explore Zepbound for Alcohol and Drug Addiction Treatment
2年前
Verastem's Avutometinib and Defactinib Combination Therapy Shows Promise in LGSOC and Other Cancers
3个月前
Beckman Foundation Awards $7.2M to 12 Young Investigators for High-Risk, High-Reward Research
8个月前
New Study Reveals ADHD Stimulants Work Through Brain's Reward and Alertness Centers, Not Attention Networks
去年
CBD Reduces Alcohol Cravings and Brain Reward Center Activity in AUD Patients
去年
House Introduces Bill for Conditional FDA Approval Pathway for Rare Disease Drugs
第 1 页,共 535 页
上一页
下一页